Germany - Cardiac Glycosides Use
Since 2014, Germany Cardiac Glycosides Use decreased by 11.4% year on year. At 2.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 5 among other countries in Cardiac Glycosides Use. Germany is overtaken by Estonia, which was ranked number 4 with 2.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Portugal at 2.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Latvia topped the ranking with 3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a decrease of 3.2% compared to 2018. Netherlands recorded the best 5 years average growth at -4.4% per year, while Chile was the worst growing country at -18.6% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 2.40 |
| 2018 | 3.00 |
| 2017 | 3.30 |
| 2016 | 3.60 |
| 2015 | 4.00 |
How does Germany rank in Cardiac Glycosides Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
3 | 2019 | -6.3 % | -5.1 % | View data | |
| 1 |
#1
Latvia
|
3 | 2019 | -3.2 % | -5.1 % | View data | |
| 4 |
#4
Estonia
|
3 | 2019 | -19.4 % | -11.1 % | View data | |
| 5 |
#5
Germany
|
2 | 2019 | -20.0 % | -11.4 % | View data | |
| 6 |
#6
Portugal
|
2 | 2019 | -8.0 % | -7.5 % | View data | |